1
|
Wang X, Luo J, Ma F, Kang G, Ding Z, Pan Y, Zhao Y, Chen J, Feng K, Yan L, Zhang J, Li L, Lan Q, Li D, Yang X, Li G, Yang J, Sun Q. The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study. Front Cell Infect Microbiol 2021; 11:672221. [PMID: 34222044 PMCID: PMC8248179 DOI: 10.3389/fcimb.2021.672221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Accepted: 06/02/2021] [Indexed: 11/26/2022] Open
Abstract
Objectives To compare the safety, immunogenicity, and immune persistence of hepatitis A (HA) vaccines between HBs-Ag-positive and -negative participants. Method 9000 participants were enrolled in the phase IV study of live attenuated HA (HA-L) or inactivated HA (HA-I) vaccines. The HBs-Ag-positive subjects were detected and became an independent observation group. Adverse reactions (ARs), geometric mean concentrations (GMCs) and seroconversion rates (SRs) of the vaccines were analyzed at five time points until three years after vaccination. Results: 120 HBs-Ag-positive subjects were screened out, only 1 participant had grade 1 experienced ARs after HA-L injection. Except the time point of two years, the SRs of HBs-Ag-positive group were 100% for both vaccines. The GMCs were not statistically different between HBs-Ag-positive and -negative groups after the HA-L vaccination. The logarithmically transformed GMCs for HBs-Ag-positive and -negative groups were 3.21 mIU/mL (95% CI, 2.03-4.39 mIU/mL) and 2.95 mIU/mL (95% CI, 2.88-3.02 mIU/mL) 28 days after the HA-L vaccination, respectively. Conclusions Both HA-L and HA-I vaccines were safe for HBs-Ag-positive participants and may provide an excellent long-term protection against HAV in this study. The results indicated that people positive or negative for HBs-Ag can receive both HA-L and HA-I vaccines (ClinicalTrials.gov number, NCT02601040).
Collapse
Affiliation(s)
- Xiaodan Wang
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Jia Luo
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Fubao Ma
- Vaccines and Immunization Department, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, China
| | - Guodong Kang
- Vaccines and Immunization Department, Jiangsu Provincial Center of Disease Control and Prevention, Nanjing, China
| | - Zhengrong Ding
- Vaccines and Immunization Department, Yunnan Provincial Center of Disease Control and Prevention, Kunming, China
| | - Yue Pan
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Yujiao Zhao
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Junying Chen
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Kai Feng
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Lingmei Yan
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Juan Zhang
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China.,School of Basic Medicine, Kunming Medical University, Kunming, China
| | - Linhao Li
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China.,School of Basic Medicine, Kunming Medical University, Kunming, China
| | - Qiangping Lan
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Daiying Li
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Xiaolei Yang
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Guoliang Li
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Jingsi Yang
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| | - Qiangming Sun
- Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Kunming, China.,Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.,Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Kunming, China
| |
Collapse
|
2
|
Wen N, Fang F, Xu W, Wang H, Zhang Y, Su Q, Liu Y, Wang H, Zhu S, Zhang X, Yu W, Yan D, Zhang Z, Tan Q, Ma F, Dong A, Liu Y, Li K, Zheng L, Hao L, Wang D, Fan C, Wu W, Luo H, Xu A, Yang W. Vaccine-Associated Paralytic Poliomyelitis - 8 PLADs, China, October 2012-March 2014. China CDC Wkly 2020; 2:955-961. [PMID: 34594814 PMCID: PMC8422190 DOI: 10.46234/ccdcw2020.260] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Accepted: 12/09/2020] [Indexed: 11/14/2022] Open
Affiliation(s)
- Ning Wen
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Fang Fang
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, Beijing, China
| | - Wenbo Xu
- National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Huaqing Wang
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Yong Zhang
- National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Qiru Su
- Chinese Center for Disease Control and Prevention, Beijing, China.,Shenzhen Children's Hospital, Shenzhen, Guangdong, China
| | - Yao Liu
- Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention; Academy of Preventive Medicine, Shandong University, Jinan, Shangdong, China
| | - Haibo Wang
- Chinese Center for Disease Control and Prevention, Beijing, China.,Clinical Research Institute, Peking University, Beijing, China
| | - Shuangli Zhu
- National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Xiaoxiao Zhang
- Henan Provincial Center for Disease Control and Prevention, Jinan, Henan, China
| | - Wenzhou Yu
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Dongmei Yan
- National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Zhenguo Zhang
- Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China
| | - Qiu Tan
- Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China
| | - Fubao Ma
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China
| | - Aihu Dong
- Guangxi Provincial Center for Disease Prevention and Control, Nanning, Guangxi, China
| | - Yu Liu
- Sichuan Provincial Center for Disease Prevention and Control, Chengdu, Sichuan, China
| | - Keli Li
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Li Zheng
- Hubei Provincial Center for Disease Prevention and Control, Wuhan, Hubei, China
| | - Lixin Hao
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Dongyan Wang
- National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Chunxiang Fan
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Wendi Wu
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Huiming Luo
- Chinese Center for Disease Control and Prevention, Beijing, China
| | - Aiqiang Xu
- Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention; Academy of Preventive Medicine, Shandong University, Jinan, Shangdong, China
| | - Weizhong Yang
- Chinese Center for Disease Control and Prevention, Beijing, China
| |
Collapse
|
3
|
Chen Y, Ma F, Xu Y, Chu X, Zhang J. Vaccines and the risk of acute disseminated encephalomyelitis. Vaccine 2018; 36:3733-3739. [PMID: 29784468 DOI: 10.1016/j.vaccine.2018.05.063] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 05/12/2018] [Accepted: 05/14/2018] [Indexed: 11/30/2022]
Abstract
BACKGROUND It is important to examine the risk of Acute disseminated encephalomyelitis (ADEM) after vaccination. METHODS We conducted a nested case-control study between January 2011 and December 2015. Four controls per case were matched for age, gender, address. An independent expert committee validated the diagnoses of cases and controls. Data on vaccinations were obtained from computerized vaccination records. The analyses were conducted with the use of conditional logistic regression. RESULTS The analyses include 272 cases of ADEM and 1096 controls. No increase in the risk of ADEM was observed for vaccination against hepatitis B, influenza, polio(live), diphtheria, pertuss(acellular), tetanusis, measles, mumps, rubella, Japanese Encephalitis, meningitis, hepatitis A, varicella and rabies vaccines. Vaccine was associated with a statistically significant increase in risk in the 31-60-day exposure interval (OR, 4.04 [95% CI, 1.07-12.69]), but not the 0-30 and 61-180-day interval. There was no association between vaccine received and the recurrence of ADEM. CONCLUSIONS Findings from the present study do not demonstrate an association of vaccines with an increased risk of ADEM and its recurrence among either paediatric (≤18 years) or adult (>18 years) individuals within the 180 days after vaccinations. The finding in children in the 31-60 day risk interval is likely coincidental and was not confirmed in separate self-control analyses.
Collapse
Affiliation(s)
- Yong Chen
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China.
| | - Fubao Ma
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China
| | - Yuanling Xu
- Department of Neurology, Nanjing Brain Hospital, China.
| | - Xuhua Chu
- Department of Neurology, Jiangsu Provincial People's Hospital, China.
| | - Jinlin Zhang
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China.
| |
Collapse
|
4
|
Li S, Ma C, Hao L, Su Q, An Z, Ma F, Xie S, Xu A, Zhang Y, Ding Z, Li H, Cairns L, Wang H, Luo H, Wang N, Li L, Ferrari MJ. Demographic transition and the dynamics of measles in six provinces in China: A modeling study. PLoS Med 2017; 14:e1002255. [PMID: 28376084 PMCID: PMC5380361 DOI: 10.1371/journal.pmed.1002255] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 02/08/2017] [Indexed: 01/27/2023] Open
Abstract
BACKGROUND Industrialization and demographic transition generate nonstationary dynamics in human populations that can affect the transmission and persistence of infectious diseases. Decades of increasing vaccination and development have led to dramatic declines in the global burden of measles, but the virus remains persistent in much of the world. Here we show that a combination of demographic transition, as a result of declining birth rates, and reduced measles prevalence, due to improved vaccination, has shifted the age distribution of susceptibility to measles throughout China. METHODS AND FINDINGS We fit a novel time-varying catalytic model to three decades of age-specific measles case reporting in six provinces in China to quantify the change in the age-specific force of infection for measles virus over time. We further quantified the impact of supplemental vaccination campaigns on the reduction of susceptible individuals. The force of infection of measles has declined dramatically (90%-97% reduction in transmission rate) in three industrialized eastern provinces during the last decade, driving a concomitant increase in both the relative proportion and absolute number of adult cases, while three central and western provinces exhibited dynamics consistent with endemic persistence (24%-73% reduction in transmission rate). The reduction in susceptible individuals due to supplemental vaccination campaigns is frequently below the nominal campaign coverage, likely because campaigns necessarily vaccinate those who may already be immune. The impact of these campaigns has significantly improved over time: campaigns prior to 2005 were estimated to have achieved less than 50% reductions in the proportion susceptible in the target age classes, but campaigns from 2005 onwards reduced the susceptible proportion by 32%-87%. A limitation of this study is that it relies on case surveillance, and thus inference may be biased by age-specific variation in measles reporting. CONCLUSIONS The age distribution of measles cases changes in response to both demographic and vaccination processes. Combining both processes in a novel catalytic model, we illustrate that age-specific incidence patterns reveal regional differences in the progress to measles elimination and the impact of vaccination controls in China. The shift in the age distribution of measles susceptibility in response to demographic and vaccination processes emphasizes the importance of progressive control strategies and measures to evaluate program success that anticipate and react to this transition in observed incidence.
Collapse
Affiliation(s)
- Sheng Li
- School of Public Health, City University of New York, New York, New York, United States of America
| | - Chao Ma
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Lixin Hao
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Qiru Su
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Zhijie An
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Fubao Ma
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China
| | - Shuyun Xie
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Aiqiang Xu
- Shandong Provincial Center for Disease Control and Prevention, Jinan, China
| | - Yanyang Zhang
- Henan Provincial Center for Disease Control and Prevention, Zhengzhou, China
| | - Zhengrong Ding
- Yunnan Provincial Center for Disease Control and Prevention, Kunming, China
| | - Hui Li
- Gansu Provincial Center for Disease Control and Prevention, Lanzhou, China
| | - Lisa Cairns
- Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Huaqing Wang
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Huiming Luo
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Ning Wang
- Nation Center for AIDS, China Centers for Disease Control and Prevention, Beijing, China
| | - Li Li
- National Immunization Program, China Centers for Disease Control and Prevention, Beijing, China
| | - Matthew J. Ferrari
- Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, United States of America
| |
Collapse
|
5
|
Kang G, Chen H, Ma F, Yang Y, Wang Z, Guo S, Song J. Comparison of the effect of increased hepatitis B vaccine dosage on immunogenicity in healthy children and adults. Hum Vaccin Immunother 2016; 12:2312-6. [PMID: 27215279 DOI: 10.1080/21645515.2016.1172757] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Hepatitis B (HepB) infection remains a global public health problem, particularly in China. Vaccination for children and adult who are unvaccinated is an effective method for preventing the disease. In this study, we aimed to compare the effects of increased dosage of HepB vaccine on immunogenicity in healthy children and adults. A phase III, controlled, double-blinded clinical trial was performed. The subjects were assigned into groups I (age 5-14 y), II (age 15-24 y), and III (age ≥ 25 y). Subjects were randomly administered either 10 or 5 μg recombinant HepB vaccine; blood samples were collected before and after vaccination to estimate immunogenicity. The results showed that the seroconversion rate and geometric mean concentration of antibody to hepB surface antigen (anti-HBs) did not differ significantly between the dosages in each age group. Anti-HBs levels were reduced with age, and this effect was more obvious in adults administered 5 μg HepB vaccine. In conclusion, both vaccine dosages could be used to immunize children, and the 10 μg vaccine could be used for adults ages 15-24 y, whereas a higher dosage of the HepB vaccine may be required for adults ages 25 y and older.
Collapse
Affiliation(s)
- Guodong Kang
- a Jiangsu Provincial Center of Disease Control and Prevention , Jiangsu Province , China
| | - Haiping Chen
- b Beijing Tiantan Biological Products Co., Ltd , Beijing , China
| | - Fubao Ma
- a Jiangsu Provincial Center of Disease Control and Prevention , Jiangsu Province , China
| | - Yunkai Yang
- b Beijing Tiantan Biological Products Co., Ltd , Beijing , China
| | - Zhiguo Wang
- a Jiangsu Provincial Center of Disease Control and Prevention , Jiangsu Province , China
| | - Shaohong Guo
- b Beijing Tiantan Biological Products Co., Ltd , Beijing , China
| | - Jiping Song
- b Beijing Tiantan Biological Products Co., Ltd , Beijing , China
| |
Collapse
|
6
|
Ma C, Gregory CJ, Hao L, Wannemuehler KA, Su Q, An Z, Quick L, Rodewald L, Ma F, Yan R, Song L, Zhang Y, Kong Y, Zhang X, Wang H, Li L, Cairns L, Wang N, Luo H. Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study, 2012-2013. Vaccine 2016; 34:6553-6560. [PMID: 27013438 PMCID: PMC6524948 DOI: 10.1016/j.vaccine.2016.02.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2015] [Revised: 01/30/2016] [Accepted: 02/01/2016] [Indexed: 11/25/2022]
Abstract
Introduction: Endemic measles persists in China, despite >95% reported coverage of two measles-containing vaccine doses and nationwide campaign that vaccinated more than 100 million children in 2010. We performed a case–control study in six Chinese provinces during January 2012 through June 2013 to identify risk factors for measles infection among children aged 0–7 months. Methods: Children with laboratory-confirmed measles were neighborhood matched with three controls. We interviewed parents of case and control infants on potential risk factors for measles. Adjusted matched odds ratios (mOR) and 95% confidence intervals (CIs) were calculated by multivariable conditional logistic modeling. We calculated attributable fractions for risk factors that could be interpreted as causal. Results: Eight hundred thirty cases and 2303 controls were enrolled. In multivariable analysis, male sex (mOR 1.6 [1.3, 2.0]), age 5–7 months (mOR 3.9 [3.0, 5.1]), migration between counties (mOR 2.3 [1.6, 3.4]), outpatient hospital visits (mOR 9.4 [6.6, 13.3]) and inpatient hospitalization (mOR 107.1 [48.8, 235.1]) were significant risk factors. The calculated attributable fractions for hospital visits was 43.1% (95% CI: 40.1, 47.5%) adjusted for age, sex and migration. Conclusions: Hospital visitation was the largest risk factor for measles infection in infants. Improved hospital infection control practices would accelerate measles elimination in China.
Collapse
Affiliation(s)
- Chao Ma
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Christopher J Gregory
- Global Immunization Division, Centers for Disease Control and Prevention, United States
| | - Lixin Hao
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
| | | | - Qiru Su
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Zhijie An
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Linda Quick
- Global Immunization Division, Centers for Disease Control and Prevention, United States
| | - Lance Rodewald
- Expanded Program on Immunization, World Health Organization Office in China, Beijing, China
| | - Fubao Ma
- Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu Province, China
| | - Rui Yan
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang Province, China
| | - Lizhi Song
- Shandong Provincial Center for Disease Control and Prevention, Shangdong Province, China
| | - Yanyang Zhang
- Henan Provincial Center for Disease Control and Prevention, Henan Province, China
| | - Yi Kong
- Yunnan Provincial Center for Disease Control and Prevention, Yunnan Province, China
| | - Xiaoshu Zhang
- Gansu Provincial Center for Disease Control and Prevention, Gansu Province, China
| | - Huaqing Wang
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Li Li
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Lisa Cairns
- Global Immunization Division, Centers for Disease Control and Prevention, United States
| | - Ning Wang
- National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Huiming Luo
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| |
Collapse
|
7
|
Kang G, Ma F, Chen H, Yang Y, Guo S, Wang Z, Liang X, Li L, Cui F, Zhang L. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers. Vaccine 2015; 33:4093-9. [DOI: 10.1016/j.vaccine.2015.06.081] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2014] [Revised: 05/19/2015] [Accepted: 06/22/2015] [Indexed: 01/27/2023]
|
8
|
Chen Y, Ma F, Xu Y, Chu X, Zhang J. Incidence of acute disseminated encephalomyelitis in the Jiangsu province of China, 2008-2011. Mult Scler J Exp Transl Clin 2015; 1:2055217315594831. [PMID: 28607697 PMCID: PMC5433407 DOI: 10.1177/2055217315594831] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2015] [Accepted: 06/15/2015] [Indexed: 11/17/2022] Open
Abstract
Background It is important to have an estimate of the incidence of acute disseminated encephalomyelitis (ADEM) because the incidence of ADEM is unknown and the outcomes undefined in China. Objectives This study attempts to describe ADEM incidence in large Chinese populations located in four geographically different and moderately distant areas of the same province. Methods A retrospective investigation was conducted with ADEM patients in Nanjing, Nantong, Yancheng and Xuzhou. The survey was carried out in regions that might have received patients meeting the case definition of ADEM provided by the International Pediatric MS Study Group from 2008 to 2011. A total of 125 hospitals were included and 412 patients were identified through the hospital information systems (HIS). Results The incidence of ADEM was 0.32/100,000/year. There are two peaks on the age-specific ADEM rates curve. One is 0.77/100,000/year among 0- to 9-year-olds, the other is 0.45/100,000/year in those aged 50–59 years. The incidence rate found for ADEM in males was 0.34/100,000/year, and in females was 0.29/100,000/year. The highest incidence rate was in Nanjing (0.40/100,000/year). Conclusions The average annual incidence of ADEM was 0.32/100,000/year. The peak age of onset was 50–59 years old and 0–9 years old. The incidence among males was insignificantly higher than that among females. There was no significant difference in incidence by seasonal variation.
Collapse
Affiliation(s)
- Yong Chen
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China
| | - Fubao Ma
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China
| | - Yuanling Xu
- Department of Neurology, Nanjing Brain Hospital, China
| | - Xuhua Chu
- Department of Neurology, Jiangsu Provincial People's Hospital, China
| | - Jinlin Zhang
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, China
| |
Collapse
|
9
|
Wang Z, Ma F, Zhang J, Yu J, Kang G, Gao J. [Evaluation of safety of haemophilus influenza type b(Hib) conjugate vaccine in postmarketing based on the immunization information management system]. Zhonghua Yu Fang Yi Xue Za Zhi 2015; 49:475-480. [PMID: 26310329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE To analyze the occurrence feature of adverse events following immunization (AEFI) of Hib conjugate vaccine (HibCV) and to evaluate the safety of HibCV in postmarketing. METHODS 2008-2013 HibCV AEFI data were collected through national AEFI information management system, which were downloaded in March 18, 2014.The demographic information and inoculation quantity of HibCV were from Immunization information management system in Jiangsu province. The incidence rate and 95% CI value of AEFI, common vaccine reaction and rare vaccine reaction following immunization of HibCV were calculated. The differences in the incidence rate of common vaccine reaction and rare vaccine reaction among sex, months of age, and number of injections were compared by means of (χ² tests. RESULTS A total of 6.16 million doses of vaccine were administered in Jiangsu province during 2008-2013, and 4 718 vaccinees reported having adverse event, for a rate of 76.60/100 000 (95% CI: 74.42/100 000-78.79/100 000). The incidence rate of common vaccine reaction and rare vaccine reaction was 71.10/100 000 (95% CI: 68.99/100 000-73.20/100 000) and 5.16/100 000 (95% CI: 4.60/100 000-5.73/100 000), respectively. The main symptoms of common vaccine reactions were fever, swelling, indurations and gastrointestinal reactions. The incidence rates of them were 40.54/100 000, 35.09/100 000, 12.94/100 000 and 0.36/100 000 in turn. The main symptoms of rare vaccine reactions were anaphylactic rashes and angioedema, the incidence rates of which were 4.77/100 000 and 0.15/100 000 respectively. 91.39% (4 002/4 379) of common vaccine reactions and 88.36% (281/318) of rare vaccine reactions happened within 1 d after vaccination. Anaphylactic shock (3 cases) and laryngeal edema (1 case) all happened within 1 d after vaccination. The incidence rate of common vaccine reactions among boys (79.72/100 000, 2 641/3 313 071) was higher than that of girls (61.07/100 000, 1 738/2 846 001) (χ² = 74.92, P < 0.001). The incidence rate of common vaccine reactions among children aged ≥ 12 month-old (86.82/100 000, 2 200/2 533 949) was higher than that among children aged 2-11 month-old (60.11/100 000, 2 179/3 625 123) (χ² = 149.79, P < 0.001). The incidence rate of common vaccine reactions in children vaccinated the first dose (78.93/100 000, 2 666/3 377 614) was higher than that in children vaccinated the second or third or fourth dose (61.59/100 000, 1 713/2 781 458) (χ² = 64.59, P < 0.001). The incidence rate of rare vaccine reactions in children vaccinated the first dose (6.69/100 000, 226/3 377 614) was higher than that in children vaccinated the second or third or fourth dose (3.31/100 000, 92/2 781 458) (χ² = 33.82, P < 0.001). CONCLUSION The safety of HibCV among children was relative good. However, the surveillance should still focus on the anaphylactoid reactions of anaphylactic shock and laryngeal edema after HibCV immunization.
Collapse
Affiliation(s)
- Zhiguo Wang
- Institute of Immunization Program, Jiangsu Center for Disease Control and Prevention, Nanjing 210009, China;
| | - Fubao Ma
- Institute of Immunization Program, Jiangsu Center for Disease Control and Prevention, Nanjing 210009, China
| | - Jinlin Zhang
- Institute of Immunization Program, Jiangsu Center for Disease Control and Prevention, Nanjing 210009, China
| | - Jing Yu
- Institute of Immunization Program, Jiangsu Center for Disease Control and Prevention, Nanjing 210009, China
| | - Guodong Kang
- Institute of Immunization Program, Jiangsu Center for Disease Control and Prevention, Nanjing 210009, China
| | - Jun Gao
- Institute of Immunization Program, Jiangsu Center for Disease Control and Prevention, Nanjing 210009, China
| |
Collapse
|
10
|
Sun CC, Shen ZY, Xiong M, Ma FB, Li YY, Chen L, Liu RM. Trend of dissolved inorganic nitrogen at stations downstream from the Three-Gorges Dam of Yangtze River. Environ Pollut 2013; 180:13-18. [PMID: 23727562 DOI: 10.1016/j.envpol.2013.05.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2013] [Revised: 04/27/2013] [Accepted: 05/01/2013] [Indexed: 06/02/2023]
Abstract
The TRAMO/SEATS program, combined with the Hodrick-Prescott (HP) filter, was used to detect trends and potential change points in time series of dissolved inorganic nitrogen (DIN) at three stations along the Yangtze River. The trend components were extracted, and two change points were successfully detected. The components revealed that DIN has been increasing at all the stations since the 1990s, although variations exist. Changes visible before 2002 illustrate the differences in agriculture development among regions upstream from the stations. The Three-Gorges Dam (TGD), which began to impound in 2003, led to years of different trends. The DIN concentration, which had been trending upward prior to that date, began a slightly downward trend because of NH4(+) depletion. Readings at the Yichang station revealed this trend most strongly; those at the Hankou station less so. The Datong station was far enough away from the TGD so that no obvious effects were seen.
Collapse
Affiliation(s)
- C C Sun
- State Key Laboratory of Water Environment Simulation, School of Environment, Beijing Normal University, Beijing 100875, PR China
| | | | | | | | | | | | | |
Collapse
|
11
|
Liu Y, Lu P, Hu Y, Wang Z, Deng X, Ma F, Tao H, Jia C, Ding X, Yang H, Liu P, Min J. Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children. PLoS One 2013; 8:e66771. [PMID: 23825562 PMCID: PMC3692513 DOI: 10.1371/journal.pone.0066771] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Accepted: 05/12/2013] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Changes in the epidemiological characteristics of measles since 2007 appeared in the Jiangsu province. Although the reported coverage with two doses of measles vaccine was greater than 95% in most regions of the province, measles incidence remained high across the whole province. Cross-sectional serological surveys of measles antibodies in the Jiangsu province of China were conducted from 2008 to 2010 to assess and track population immunity. METHODS Measles-specific IgG levels were measured in serum samples using ELISA. GMTs and seroprevalence with 95% CIs were calculated by region, gender, and age. ANOVA and χ(2) tests were used to test for statistically significant differences between groups for GMT levels and seroprevalence, respectively. RESULTS Seroprevalence showed a significantly increasing trend annually (CMH χ(2) = 40.32, p<0.0001). Although the seroprevalence among children aged 2-15 years was consistently over 95%, vaccine-induced measles antibodies may wane over time. Measles seropositivity in the Jiangsu province was 91.7% (95% CI: 90.1-93.2%) in 2010. Among adults aged 15 to 29-year-olds, the seropositivity rate was 88.4% (95% CI: 82.7-92.8%). CONCLUSIONS Vaccination strategies may need to be adjusted depending on the individual age and regions, particularly individuals between the ages of 8 months-14 years old and 20-29 years old. Additional SIAs are likely required to eliminate measles in China.
Collapse
Affiliation(s)
- Yuanbao Liu
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Peishan Lu
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Ying Hu
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Zhiguo Wang
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Xiuying Deng
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Fubao Ma
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Hong Tao
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Chengmei Jia
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Xiaoyan Ding
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Haitao Yang
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Pei Liu
- Department of Biostatistics and Epidemiology, School of Public Health, Southeast University, Nanjing, Jiangsu Province, China
| | - Jie Min
- Department of Biostatistics and Epidemiology, School of Public Health, Southeast University, Nanjing, Jiangsu Province, China
| |
Collapse
|
12
|
Liu Y, Tao H, Ma F, Lu P, Hu Y, Ding X, Liu P, Min J, Li J, Sun J, Xiao S. Sero-epidemiology of measles in general population in Jiangsu province of China: application of mixture models to interpret the results from a cross-sectional study. Vaccine 2010; 29:1000-4. [PMID: 21163248 DOI: 10.1016/j.vaccine.2010.11.081] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2010] [Revised: 11/06/2010] [Accepted: 11/16/2010] [Indexed: 10/18/2022]
Abstract
A cross-sectional survey of measles seroprevalence in general population was conducted in Jiangsu province of China. Data were analyzed by employing commercial ELISA cut-offs and mixture models. The results suggest that the overall measles seroprevalence rate in Jiangsu province (88.7%, 95% confidence interval 87.7-89.6%) was lower than the level believed to be necessary for the elimination of measles. Mixture model could provide a more comprehensive understanding of these results by investigating the different levels of antibody response to vaccination or natural infection in the population, and suggest that the vaccine-induced antibody levels may wane with time. Additional actions should be conducted in the young adult cohorts aged 15-19 years in center region. SIAs for susceptible birth cohorts over the whole province are urgent.
Collapse
Affiliation(s)
- Yuanbao Liu
- Department of Expanded Programme on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province 210009, China.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Ma FB, Luo LY, Zhang LH. [Study on epidemiological effect of the freeze-dried attenuated live varicella vaccine]. Zhongguo Yi Miao He Mian Yi 2009; 15:193-195. [PMID: 20084878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
OBJECTIVE To evaluate the safety and epidemiological effect of the Freeze-dried Live attenuated varicella vaccine. METHODS A random, double-blind control clinical trial was adopted. RESULTS In the observation period, the incidence of varicella was 0.8 per thousand in the experimental group and 8.7 per thousand in control group. There was a significant difference (B.P=0.000017). Vaccine effectiveness (VE(%)) was 90.8%, the lower limit of 95%CI was 88.7%. CONCLUSION The varicella vaccine produced by Changchun keygen biological products co., Ltd. was safe and effective.
Collapse
Affiliation(s)
- Fu-bao Ma
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, Jiangsu, China
| | | | | |
Collapse
|
14
|
Ma FB, Zheng L, Bi C, Tao H, Zhou YL, Zhang JL, Tang FY, Xie P, Zheng CZ, Peng WB, Jiang RJ. [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine]. Zhonghua Liu Xing Bing Xue Za Zhi 2003; 24:113-5. [PMID: 12697111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
OBJECTIVE Using the advantages of Japanese encephalitis live attenuated and inactivated vaccine, to reduce the rate of immunization reaction and to increase the effect, we conducted a study on the strategy of immunization in Japanese encephalitis using live attenuated vaccine combined with inactivated vaccine. METHODS Observing the safety and immune effects of different groups. RESULTS Data on side effect showed that the rate of moderate and severe systematic reactions of the group who were inoculated with combined vaccine was 0.73%, with local reaction 1.46% while the combined rate of moderate and severe systematic reaction of the group who were inoculated with inactivated vaccine was 2.8%. Under the detection of serum neutralizing antibody, the GMT rose from 1:1.05 - 1:3.35 before vaccination to 1:47.34 - 1:101.30 after vaccination in the different groups. Neutralizing antibody was detected in 97.67% of the combined group. There was a significant difference by comparing neutralizing antibody seroconversion rate of the combined group with the inactivated group (chi(2) = 3.89, P < 0.05), but no significant difference with attenuated group (chi(2) = 0.74, P > 0.05). CONCLUSION Results showed that in children who previously had been immunized with two doses of inactivated vaccine, the booster administration of live attenuated vaccine was both effective and safe.
Collapse
Affiliation(s)
- Fu-bao Ma
- Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210009, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Diao LD, Ma FB, Tao H. [Supervision and evaluation of vaccination coverage rates in Jiangsu province]. Zhonghua Liu Xing Bing Xue Za Zhi 1996; 17:134-5. [PMID: 9208506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Comprehensively, this paper evaluated the actual vaccination coverage rates in Jiangsu province, using geometric averages to weigh vaccination coverage rates through a) regular and irregular investigation b) conventional report rates and c) registration rates of children at the right age of vaccination. Results showed that the comprehensive method of using vaccination coverage rates for evaluation was better than the conventioned index which had been used before.
Collapse
Affiliation(s)
- L D Diao
- Jiangsu Provincial Hygiene and Epidemic Prevention Station, Nanjing
| | | | | |
Collapse
|
16
|
Yang YS, Zhou YX, Ma FB, Shan CW. Effect of procainamide on platelet adhesion in rats. Zhongguo Yao Li Xue Bao 1994; 15:339-40. [PMID: 7801777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Effect of procainamide on platelet adhesion in rats was studied with the improved rotating glass sphere method. Procainamide of 136.0, 34.0, 8.5 mumol.L-1 in vitro and 10 mg.kg-1 in vivo inhibited significantly the platelet adhesion with the inhibitory rates of 56%, 28%, 8%, and 24%, respectively. It showed that procainamide given in vitro or in vivo produced an inhibition on platelet adhesion.
Collapse
Affiliation(s)
- Y S Yang
- Department of Physics, First Military Medical University, Guangzhou, China
| | | | | | | |
Collapse
|